东诚药业 (002675.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(单季度)(东诚药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年第三季度2023年第二季度2023年第一季度2022年第四季度2022年第三季度2022年第二季度2022年第一季度
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 800,333,136.57934,509,977.98850,500,484.35841,514,137.97976,379,356.21885,325,662.74879,736,270.21
 营业收入(元) 800,333,136.57934,509,977.98850,500,484.35841,514,137.97976,379,356.21885,325,662.74879,736,270.21
二、营业总成本(元) 679,317,202.29751,248,872.65764,778,405.24778,757,550.30751,912,714.61719,819,745.48784,154,746.93
 营业成本(元) 463,750,806.33541,945,464.79447,006,265.63458,028,496.91525,963,045.42515,418,377.22544,965,300.13
 研发费用(元) 40,829,872.0836,610,891.9247,321,769.4764,256,277.1331,670,840.7430,309,806.2037,283,568.45
 营业税金及附加(元) 8,287,571.548,695,009.347,751,517.917,747,506.568,184,347.747,139,721.026,116,747.76
 销售费用(元) 103,393,436.66137,689,377.90165,018,368.72155,478,493.89151,362,946.36132,804,097.33126,474,387.77
 管理费用(元) 52,967,193.5855,278,830.3977,572,608.9261,423,508.9752,688,955.0357,203,193.8553,973,674.71
 财务费用(元) 10,088,322.10-28,970,701.6920,107,874.5931,823,266.84-17,957,420.68-23,055,450.1415,341,068.11
  其中:利息费用(元) 10,663,469.4310,196,535.1010,961,264.4913,224,685.0015,575,953.1214,949,335.7214,891,135.56
  其中:利息收入(元) 2,722,833.122,645,779.863,406,131.546,324,257.272,173,630.632,423,914.932,275,115.79
 信用减值损失(元) 2,202,694.824,386,328.27-1,562,467.80-840,660.50-2,279,424.492,204,396.17-4,234,328.91
三、其他经营收益
 加:公允价值变动收益(元) ---226,667.3119,945.21--
 加:投资收益(元) 7,659,949.43139,133.43-7,055,328.88-13,610,963.88-9,211,146.43-8,848,908.37-7,942,759.92
  其中:对联营企业和合营企业的投资收益(元) -13,626,968.97------
 资产处置收益(元) -1,640.2634,139.883,261.96233,577.74-1,208.25-54,723.44-44,079.40
 其他收益(元) 4,369,612.583,513,610.689,589,346.8613,751,143.193,605,734.294,703,526.592,400,059.58
四、营业利润(元) 135,432,447.81191,334,317.5986,696,891.25-17,774,103.04210,656,135.96169,609,086.5985,760,414.63
 加:营业外收入(元) 49,675.70212,012.169,471.27103,694.66-19,007.2948,222.7637,019.02
 减:营业外支出(元) 411,186.22304,249.49116,004.921,142,373.16396,514.83290,001.601,016,117.58
五、利润总额(元) 135,070,937.29191,242,080.2686,590,357.60-18,812,781.54210,240,613.84169,367,307.7584,781,316.07
 减:所得税费用(元) 17,440,491.1731,090,867.4523,675,382.5111,160,843.7429,805,027.7233,206,025.0618,588,137.72
六、净利润(元) 117,630,446.12160,151,212.8162,914,975.09-29,973,625.28180,435,586.12136,161,282.6966,193,178.35
(一)按经营持续性分类
  持续经营净利润(元) 117,630,446.12160,151,212.8162,914,975.09-29,973,625.28180,435,586.12136,161,282.6966,193,178.35
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 101,505,127.46134,199,772.1250,106,641.46-23,020,841.93161,570,690.08113,817,760.6454,921,850.86
  少数股东损益(元) 16,125,318.6625,951,440.6912,808,333.63-6,952,783.3518,864,896.0422,343,522.0511,271,327.49
 扣除非经常性损益后的净利润(元) 77,268,744.13131,037,054.2642,389,249.65-34,194,148.10158,711,951.89109,617,603.4753,663,643.01
七、每股收益
 一、基本每股收益(元) 0.120.160.06-0.030.200.140.07
 二、稀释每股收益(元) 0.120.160.06-0.030.200.140.07
八、其他综合收益(元) 27,699.66598,233.42-2,513,718.7613,127,231.603,308,710.064,386,794.64-2,354,776.35
 归属于母公司股东的其他综合收益(元) 1,772,926.94-47,527.59-2,463,157.2010,214,945.074,187,290.464,424,961.64-2,198,865.35
 归属于少数股东的其他综合收益(元) -1,745,227.28645,761.01-50,561.562,912,286.53-878,580.40-38,167.00-155,911.00
九、综合收益总额(元) 117,658,145.78160,749,446.2360,401,256.33-16,846,393.68183,744,296.18140,548,077.3363,838,402.00
 归属于母公司所有者的综合收益总额(元) 103,278,054.40134,152,244.5347,643,484.26-12,805,896.86165,757,980.54118,242,722.2852,722,985.51
 归属于少数股东的综合收益总额(元) 14,380,091.3826,597,201.7012,757,772.07-4,040,496.8217,986,315.6422,305,355.0511,115,416.49
公告日期 2023-10-272023-08-242023-04-292023-04-292022-10-282022-08-262022-04-29
审计意见(境内) 标准无保留意见

前瞻产业研究院